Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppression for islet transplantation.

Hirofumi Noguchi1, Shinichi Matsumoto, Masayuki Matsushita

  • 1Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan. noguchih@kuhp.kyoto-u.ac.jp

Acta Medica Okayama
|May 9, 2006
PubMed
Summary

A new sirolimus-based, steroid-free regimen significantly boosts insulin independence after islet transplantation to 80% at 1 year. However, long-term efficacy is impacted by prolonged immunosuppression, necessitating novel therapeutic strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vivo activities of E1 elements in the insulin promoter.

Communications biology·2026
Same author

Comparative Analysis of Induced Pancreatic Stem Cells Generated with Different Factors.

Human gene therapy·2026
Same author

Addition of human platelet lysate to islet culture medium suppresses islet loss and improves transplantation outcomes.

Cell transplantation·2026
Same author

Efficacy and Safety of Allogeneic Islet Transplantation Demonstrated by a Multicenter Clinical Trial in Japan.

Transplantation direct·2025
Same author

Scratch-Based Isolation of Primary Cells (SCIP): A Novel Method to Obtain a Large Number of Human Dental Pulp Cells Through One-Step Cultivation.

Journal of clinical medicine·2024
Same author

Compound 4f, a novel brain-penetrant reversible monoacylglycerol inhibitor, ameliorates neuroinflammation, neuronal cell loss, and cognitive impairment in mice with kainic acid-induced neurodegeneration.

PloS one·2024

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Endocrinology

Background:

  • Islet transplantation offers a potential cure for type 1 diabetes.
  • Current immunosuppression protocols face challenges with long-term efficacy and side effects.
  • Optimizing immunosuppression is critical for sustained insulin independence post-transplant.

Purpose of the Study:

  • To review recent advancements in immunosuppression for islet transplantation.
  • To highlight novel strategies for improving long-term outcomes.
  • To discuss the evolution of immunosuppressive agents and their impact on insulin independence.

Main Methods:

  • Review of recent literature on immunosuppression in islet transplantation.
  • Analysis of sirolimus-based, steroid-free, low-tacrolimus regimens.

Related Experiment Videos

  • Exploration of alternative immunosuppressive agents and novel technologies.

    • Main Results:

    • A sirolimus-based, steroid-free, low-tacrolimus regimen increased 1-year insulin independence from 13% to 80%.
    • Insulin independence decreased to 50% at 3 years, linked to prolonged tacrolimus exposure.
    • Emerging agents like FTY720, lymphocyte-depleting antibodies, and costimulatory blockade show promise.

    Conclusions:

    • Novel immunosuppression strategies are crucial for enhancing long-term insulin independence after islet transplantation.
    • Reducing reliance on prolonged tacrolimus may mitigate long-term complications.
    • Future research directions include exploring novel peptides and advanced delivery systems like protein transduction.